CASTLE BIOSCIENCES, INC. Financing Cash Flow
CASTLE BIOSCIENCES, INC. (CSTL) reported Financing Cash Flow of -$5.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$886.00K, a 977.23% decline year-over-year.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$5.03M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$4.59M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$919.00K, a 209.67% decline year-over-year.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2025 was -$6.96M, a 213.37% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2024 was $6.14M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$2.30M, a 251.68% decline from fiscal 2022.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2022 was $1.51M, a 72.05% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$886.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$5.92M 10-Q · filed 2026-07-30 | -$10.51M derived: sum of 3 quarters · filed 2026-07-30 | -$11.43M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | -$5.03M 10-Q · filed 2026-05-06 | -$9.62M derived: sum of 2 quarters · filed 2026-05-06 | -$10.54M derived: sum of 3 quarters · filed 2026-05-06 | -$10.44M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | -$4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.51M derived: sum of 2 quarters · filed 2026-02-26 | -$5.41M derived: sum of 3 quarters · filed 2026-07-30 | -$6.96M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | -$919.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$818.00K derived: sum of 2 quarters · filed 2026-07-30 | -$2.37M 10-Q · filed 2025-11-03 | -$7.76M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$1.45M 10-Q · filed 2026-07-30 | -$6.84M derived: sum of 3 quarters · filed 2026-07-30 | -$6.00M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | -$1.55M 10-Q · filed 2026-05-06 | -$6.94M derived: sum of 2 quarters · filed 2026-05-06 | -$6.10M derived: sum of 3 quarters · filed 2026-05-06 | -$6.06M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.55M derived: sum of 2 quarters · filed 2026-02-26 | -$4.50M derived: sum of 3 quarters · filed 2026-02-26 | $6.14M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $838.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $880.00K derived: sum of 2 quarters · filed 2025-11-03 | $11.52M 10-Q · filed 2025-11-03 | $8.23M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $10.69M 10-Q · filed 2025-08-04 | $7.39M derived: sum of 3 quarters · filed 2026-02-26 | $7.43M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $10.64M 10-Q · filed 2025-05-05 | $7.35M derived: sum of 2 quarters · filed 2026-02-26 | $7.39M derived: sum of 3 quarters · filed 2026-02-26 | $7.62M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | -$3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.25M derived: sum of 2 quarters · filed 2026-02-26 | -$3.03M derived: sum of 3 quarters · filed 2026-02-26 | -$2.30M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $271.00K derived: sum of 2 quarters · filed 2024-11-04 | $999.00K 10-Q · filed 2024-11-04 | $249.00K derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $954.00K 10-Q · filed 2024-08-05 | $204.00K derived: sum of 3 quarters · filed 2025-02-27 | $592.00K derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $728.00K 10-Q · filed 2024-05-02 | -$22.00K derived: sum of 2 quarters · filed 2025-02-27 | $366.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.03M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$362.00K derived: sum of 2 quarters · filed 2025-02-27 | $299.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.51M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.05M derived: sum of 2 quarters · filed 2023-11-02 | $2.27M 10-Q · filed 2023-11-02 | $2.39M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | $661.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.88M 10-Q · filed 2023-08-02 | $2.00M derived: sum of 3 quarters · filed 2023-08-02 | $3.90M derived: sum of 4 quarters · filed 2023-08-02 | ||
| 2022-03-31 | $1.22M 10-Q · filed 2023-05-03 | $1.34M derived: sum of 2 quarters · filed 2023-05-03 | $3.24M derived: sum of 3 quarters · filed 2023-05-03 | $5.13M derived: sum of 4 quarters · filed 2023-05-03 | ||
| 2021-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.02M derived: sum of 2 quarters · filed 2023-02-28 | $3.91M derived: sum of 3 quarters · filed 2023-02-28 | $5.42M 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $3.79M derived: sum of 2 quarters · filed 2022-11-02 | $5.29M 10-Q · filed 2022-11-02 | $233.12M derived: sum of 4 quarters · filed 2022-11-02 | ||
| 2021-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.40M 10-Q · filed 2022-08-08 | $231.22M derived: sum of 3 quarters · filed 2022-08-08 | $239.37M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | $1.51M 10-Q · filed 2022-05-09 | $229.33M derived: sum of 2 quarters · filed 2022-05-09 | $237.48M derived: sum of 3 quarters · filed 2022-05-09 | $306.84M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $227.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $235.97M derived: sum of 2 quarters · filed 2022-02-28 | $305.33M derived: sum of 3 quarters · filed 2022-02-28 | $305.89M 10-K · filed 2022-02-28 | ||
| 2020-09-30 | $8.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $77.51M derived: sum of 2 quarters · filed 2021-11-08 | $78.07M 10-Q · filed 2021-11-08 | $78.29M derived: sum of 4 quarters · filed 2021-11-08 | ||
| 2020-06-30 | $69.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $69.92M 10-Q · filed 2021-08-09 | $70.14M derived: sum of 3 quarters · filed 2021-08-09 | $146.56M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $559.00K 10-Q · filed 2021-05-10 | $783.00K derived: sum of 2 quarters · filed 2021-05-10 | $77.20M derived: sum of 3 quarters · filed 2021-05-10 | $78.14M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $76.64M derived: sum of 2 quarters · filed 2021-03-11 | $77.58M derived: sum of 3 quarters · filed 2021-03-11 | $88.29M 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $76.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $77.36M derived: sum of 2 quarters · filed 2020-11-09 | $88.06M 10-Q · filed 2020-11-09 | $88.06M 10-Q · filed 2019-11-12 | $92.48M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $936.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $11.64M 10-Q · filed 2020-08-10 | $11.64M 10-Q · filed 2019-09-03 | $16.06M derived: sum of 3 quarters · filed 2020-08-10 | $16.10M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $10.71M 10-Q · filed 2020-05-11 | $15.13M derived: sum of 2 quarters · filed 2020-05-11 | $15.16M derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $4.46M derived: sum of 2 quarters · filed 2020-03-10 | $15.84M 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $36.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $11.42M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $11.38M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |